Filing Details
- Accession Number:
- 0001104659-22-092658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-18 18:53:47
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-08-18 18:53:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689375 | Entrada Therapeutics Inc. | TRDA | Pharmaceutical Preparations (2834) | 813983399 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1725663 | James Kory Wentworth | C/O Entrada Therapeutics, Inc. 6 Tide Street Boston MA 02210 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-16 | 100 | $2.10 | 20,641 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-16 | 200 | $13.00 | 20,441 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-17 | 100 | $2.10 | 20,541 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-17 | 200 | $13.07 | 20,341 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-18 | 100 | $2.10 | 20,441 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-18 | 200 | $13.00 | 20,221 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-16 | 100 | $0.00 | 100 | $2.10 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-17 | 100 | $0.00 | 100 | $2.10 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-08-18 | 100 | $0.00 | 100 | $2.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 116,096 | 2030-11-10 | No | 4 | M | Direct | |
| 115,996 | 2030-11-10 | No | 4 | M | Direct | |
| 115,896 | 2030-11-10 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.
- 25% of the shares subject to this option shall vest and become exercisable on November 16, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
